Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07731880) titled 'Influencing Next-Generation Oncologic Outcomes Through Rapid Integration of Functional Precision Medicine (NOORI): A Feasibility Study of SmartMatch in Rare Gynecologic Cancers' on July 23.

Study Type: Observational

Primary Sponsor: Fred Hutchinson Cancer Center

Condition: Malignant Female Reproductive System Neoplasm Metastatic Malignant Female Reproductive System Neoplasm Unresectable Malignant Female Reproductive System Neoplasm

Recruitment Status: Not recruiting

Date of First Enrollment: September 2026

Target Sample Size: 30

Countries of Recruitment: United States

To know more, visit https://clinicaltria...